Thomas C. Marbury, MD
Orlando Clinical Research Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Thomas C. Marbury, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:44 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06084104 · DZD9008 PK Study in Hepatic Impairment SubjectsDizal Pharmaceuticals · completed · Hepatic Impairment
- Ph1NCT05283746 · A Study of Epetraborole Tablets in Subjects With Degrees of Renal FunctionAN2 Therapeutics, Inc · completed · Renal Insufficiency
- Ph1NCT03401528 · A Phase 1 AVB-S6-500 Safety and Tolerability StudyAravive, Inc. · completed · Healthy Volunteer
- Ph1NCT02063230 · To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy SubjectsAstraZeneca · completed · Solid Tumors
- Ph1NCT02063204 · To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy SubjectsAstraZeneca · completed · Solid Tumours
- Ph1NCT00728689 · Phase I Trial of an Investigational Small Pox MedicationSIGA Technologies · completed · Orthopoxviral Disease, Smallpox, Monkey Pox
- Ph1/Ph2NCT00550849 · Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic DysfunctionBiogen · terminated · Liver Disease · principal investigator
- Ph1NCT00546650 · Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®NuPathe Inc. · completed · Healthy
- Ph1NCT00431951 · Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy VolunteersSIGA Technologies · completed · Healthy
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.